BILL · 2023–24 SESSION · LATEST VERSION SSB 5388

SB 5388: Diversity in clinical trials

Concerning improving diversity in clinical trials.

Summary

  • Requires the University of Washington, Washington State University, and any hospital or state agency that receives National Institutes of Health funding for drug and medical device clinical trials to offer information in a language other than English, to provide culturally specific recruitment materials, and to provide electronic consent when available.
  • Codifies the Washington State Institutional Review Board (Review Board).
  • Requires the Review Board and the Andy Hill Cancer Research Endowment to consider in their evaluation four factors related to increasing participation of underrepresented communities in clinical trials of drugs and medical devices.
  • Requires the Department of Health, in consultation with research and community-based entities, to study and provide recommendations on increasing access to clinical trials and participation in clinical trials by persons who are members of underrepresented communities.

From the Substitute House Bill Report (SSB 5388), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · passed Senate, stalled in House
  1. IntroducedJan 16, 2023
  2. Out of committeeFeb 24, 2023
  3. Passed SenateMar 6, 2023
  4. Passed Housestopped here
  5. Governor
  6. Law
Prime sponsor
Senator (R-18)
Introduced
January 16, 2023 in the Senate
Last action
January 8, 2024
Budget
Has a fiscal note
Versions
SB 5388, SSB 5388

AN ACT Relating to improving diversity in clinical trials;

Sponsors

Votes

Senate · 3rd Reading & Final Passage

Passed March 6, 2023
Version voted on: SSB 5388
48 Yea 0 Nay 0 Absent 1 Excused
PartyYeaNayAbsentExcused
Democrat28001
Republican20000
How each member voted

History

  1. Senate Rules "X" file. (SSB 5388)
  2. By resolution, reintroduced and retained in present status. (SSB 5388)
  3. By resolution, returned to Senate Rules Committee for third reading. (SSB 5388)
  4. Minority; do not pass. (SSB 5388)
  5. APP - Majority; do pass with amendment(s) by Health Care & Wellness. (SSB 5388)
  6. APP - Executive action taken by committee. (SSB 5388)
  7. Referred to Rules 2 Review. (SSB 5388)
  8. Minority; without recommendation. (SSB 5388)
  9. Minority; do not pass. (SSB 5388)
  10. HCW - Majority; do pass with amendment(s). (SSB 5388)
  11. HCW - Executive action taken by committee. (SSB 5388)
  12. Referred to Appropriations. (SSB 5388)
  13. First reading, referred to Health Care & Wellness. (SSB 5388)
  14. Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1. (SSB 5388)
  15. Rules suspended. Placed on Third Reading. (SSB 5388)
  16. 1st substitute bill substituted. (SSB 5388)
  17. 1st substitute bill substituted.
  18. Placed on second reading by Rules Committee. (SSB 5388)
  19. Placed on second reading by Rules Committee.
  20. Passed to Rules Committee for second reading. (SSB 5388)
  21. Passed to Rules Committee for second reading.
  22. Minority; without recommendation. (SSB 5388)
  23. WM - Majority; do pass 1st substitute bill proposed by Health & Long Term Care. (SSB 5388)
  24. WM - Majority; do pass 1st substitute bill proposed by Health & Long Term Care.
  25. Minority; without recommendation.
  26. Referred to Ways & Means. (SSB 5388)
  27. Referred to Ways & Means.
  28. HLTC - Majority; 1st substitute bill be substituted, do pass. (SSB 5388)
  29. And refer to Ways & Means. (SSB 5388)
  30. And refer to Ways & Means.
  31. HLTC - Majority; 1st substitute bill be substituted, do pass.
  32. First reading, referred to Health & Long Term Care.

SB 5388 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page